Enhanced agglutination reaction of ABO subgroups by gold nanoparticle solution: Implication for identification of ABO subgroups

Journal of Biomedical Nanotechnology

Volumn 7, Issue 6, 2011, Pages 840-845

  Ammaranond, P ^a   Sriyarak, J ^a   Saejong, S ^a   Deesin, P ^b   Seereemaspun, A ^a   Rojanathanes, R ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

Author keywords

ABO discrepancies; ABO subgroups; Gold nanoparticle solution

Indexed keywords

ABO DISCREPANCIES; ABO SUBGROUPS; BLOOD GROUP; CELL GROUPING; CELL SUSPENSION; GOLD NANOPARTICLE SOLUTION; GOLD NANOPARTICLES; RED BLOOD CELL; SUPERNATANTS;

ANTIGEN-ANTIBODY REACTIONS; ANTIGENS; BACTERIA; BLOOD; CELL CULTURE; CELLS; DENSITY (OPTICAL); DENSITY MEASUREMENT (OPTICAL); GOLD; MONOCLONAL ANTIBODIES;

NANOPARTICLES;

GOLD NANOPARTICLE; MONOCLONAL ANTIBODY;

ADULT; ANTIGEN ANTIBODY REACTION; ARTICLE; BLOOD GROUP ABO SYSTEM; BLOOD GROUP TYPING; CELL SUSPENSION; FEMALE; HUMAN; MALE; OPTICAL DENSITY; SPECTROPHOTOMETER; SUPERNATANT;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; AGGLUTINATION TESTS; BLOOD GROUPING AND CROSSMATCHING; FEMALE; GOLD; HUMANS; MALE; METAL NANOPARTICLES; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY;

EID: 84856859143     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2011.1351     Document Type: Article

References (61)

1. M. L. Olsson, N. M. Irshaid, B. Hosseini-Maaf, A. Hellberg, M. K. Moulds, H. Sareneva, and M. A. Chester, Genomic analysis of clinical samples with serologic ABO blood grouping discrepancies: Identification of 15 novel A and B subgroup alleles. Blood 98, 1585 (2001).
2. M. A. Ferguson-Smith, D. A. Aitken, C. Turleau, and J. de Grouchy, Localisation of the human ABO: Np-1: AK-1 linkage group by regional assignment of AK-1 to 9q34. Hum. Genet. 34, 35 (1976).
3. E. P. Bennett, R. Steffensen, H. Clausen, D. O. Weghuis, and A. G. van Kessel, Genomic cloning of the human histo-blood group ABO locus. Biochem. Biophys. Res. Commun. 206, 318 (1995).
4. W. M. Watkins, Biochemistry and genetics of the ABO, lewis, and P blood group systems. Adv. Hum. Genet. 10, 379 (1980).
5. F. Yamamoto, P. D. McNeill, M. Yamamoto, S. Hakomori, T. Harris, W. J. Judd, and R. D. Davenport, Molecular genetic analysis of the ABO blood group system: 1. Weak subgroups: A3 and B3 alleles. Vox. Sang. 64, 116 (1993).
6. E. Boix, G. J. Swaminathan, Y. Zhang, R. Natesh, K. Brew, and K. R. Acharya, Structure of UDP complex of UDP-galactose: Beta-galactoside-alpha-1,3- galactosyltransferase at 1.53-A resolution reveals a conformational change in the catalytically important C terminus. J. Biol. Chem. 276, 48608 (2001).
7. R. Mollicone, I. Reguigne, R. J. Kelly, A. Fletcher, J. Watt, S. Chatfield, A. Aziz, H. S. Cameron, B. W. Weston, and J. B. Lowe, Molecular basis for Lewis alpha(1,3/1,4)-fucosyltransferase gene deficiency (FUT3) found in Lewis-negative Indonesian pedigrees. J. Biol. Chem. 269, 20987 (1994).
8. F. Dupuy, J. M. Petit, R. Mollicone, R. Oriol, R. Julien, and A. Maftah, A single amino acid in the hypervariable stem domain of vertebrate alpha1,3/1,4-fucosyltransferases determines the type 1/type 2 transfer. Characterization of acceptor substrate specificity of the lewis enzyme by site-directed mutagenesis. J. Biol. Chem. 274, 12257 (1999).
9. N. Yang and B. Boettcher, Conversion of the human blood group H antigen to A antigen in vitro. Immunol. Cell. Biol. 69, 111 (1991).
10. R. Ying and K. Furukawa, Fungal anti-A agglutinins with different affinities for subgroups A1 and A2 red cells. Exp. Clin. Immunogenet. 12, 232 (1995).
11. A. Seifner, P. Lieberzeit, C. Jungbauer, and F. L. Dickert, Synthetic receptors for selectively detecting erythrocyte ABO subgroups. Anal. Chim. Acta. 651, 215 (2009).
12. P. K. Das, S. C. Nair, V. K. Harris, D. Rose, J. J. Mammen, Y. N. Bose, and A. Sudarsanam, Distribution of ABO and Rh-D blood groups among blood donors in a tertiary care centre in South India. Trop. Doct. 31, 47 (2001).
13. O. Nathalang, S. Kuvanont, P. Punyaprasiddhi, C. Tasaniyanonda, and T. Sriphaisal, A preliminary study of the distribution of blood group systems in Thai blood donors determined by the gel test. Southeast. Asian. J. Trop. Med. Public. Health 32, 204 (2001).
14. L. Yan, F. Zhu, Q. Fu and J. He, ABO, Rh, MNS, Duffy, Kidd, Yt, Scianna, and Colton blood group systems in indigenous Chinese. Immunohematology 21, 10 (2005).
15. J. Mwangi, Blood group distribution in an urban population of patient targeted blood donors. East. Afr. Med. J. 76, 615 (1999).
16. F. Yamamoto, P. D. McNeill, Y. Kominato, M. Yamamoto, S. Hakomori, S. Ishimoto, S. Nishida, M. Shima, and Y. Fujimura, Molecular genetic analysis of the ABO blood group system: 2. cis- AB alleles. Vox. Sang. 64, 120 (1993).
17. F. Yamamoto, P. D. McNeill, M. Yamamoto, S. Hakomori, I. M. Bromilow, and J. K. Duguid, Molecular genetic analysis of the ABO blood group system: 4. Another type of O allele. Vox. Sang. 64, 175 (1993).
18. F. Yamamoto, P. D. McNeill, M. Yamamoto, S. Hakomori, and T. Harris, Molecular genetic analysis of the ABO blood group system: 3. A(X) and B(A) alleles. Vox. Sang. 64, 171 (1993).
19. F. Akbas, M. Aydin, and A. Cenani, AB0 blood subgroup allele frequencies in the Turkish population. Anthropol. Anz. 61, 257 (2003).
20. L. Dean, Blood Groups and Red cell Antigens, National Library of Medicine, Bethesda (2005).
21. M. Reid, C. Lomas-Francis, The Blood Group Antigen Factsbook, Academic Press (2004).
22. S. Shastry and S. Bhat, Imbalance in A and AB phenotype frequency of ABO group in South India., Blood. Transfus. 8, 267-270 (2010).
23. G. Stussi, J. Muntwyler, J. R. Passweg, L. Seebach, U. Schanz, J. Gmur, A. Gratwohl, and J. D. Seebach, Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation. Bone. Marrow. Transplant. 30, 87 (2002).
24. P. Rozman, A. Kosir, and M. Bohinjec, Is the ABO incompatibility a risk factor in bone marrow transplantation? Transpl. Immunol. 14, 159 (2005).
25. C. Canals, E. Muniz-Diaz, C. Martinez, R. Martino, I. Moreno, A. Ramos, M. Arilla, N. Boto, C. Pastoret, A. Remacha, J. Sierra, and P. Madoz, Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning. Transfusion. 44, 1603 (2004).
26. J. G. Kim, S. K. Sohn, D. H. Kim, J. H. Baek, K. B. Lee, W. S. Min, C. C. Kim, M. H. Lee, J. J. Lee, I. J. Chung, H. J. Kim, and J. W. Lee, Impact of ABO incompatibility on outcome after allogeneic peripheral blood stem cell transplantation. Bone. Marrow. Transplant. 35, 489 (2005).
27. I. B. Resnick, P. D. Tsirigotis, M. Y. Shapira, M. Aker, M. Bitan, S. Samuel, A. Abdul-Hai, A. Ackerstein, R. Or, and S. Slavin, ABO incompatibility is associated with increased non-relapse and GVHD related mortality in patients with malignancies treated with a reduced intensity regimen: A single center experience of 221 patients. Biol. Blood. Marrow. Transplant. 14, 409 (2008).
28. N. Worel, H. T. Greinix, B. Schneider, M. Kurz, W. Rabitsch, P. Knobl, E. Reiter, K. Derfler, G. Fischer, W. Hinterberger, P. Hocker, and P. Kalhs, Regeneration of erythropoiesis after relatedand unrelated-donor BMT or peripheral blood HPC transplantation: A major ABO mismatch means problems. Transfusion. 40, 543 (2000).
29. W. Rabitsch, P. Knobl, E. Prinz, F. Keil, H. Greinix, P. Kalhs, N. Worel, M. Jansen, W. H. Horl, and K. Derfler, Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: Removal of persisting isohemagglutinins with Ig-Therasorb immunoadsorption. Bone. Marrow. Transplant. 32, 1015 (2003).
30. V. P. Retel, M. J. Hummel, and W. H. van Harten, Review on early technology assessments of nanotechnologies in oncology. Mol. Oncol. 3, 394 (2009).
31. K. Matsuo, Y. Ishii, T. Yoshinaga, M. Akashi, Y. Mukai, Y. Yoshioka, N. Okada, and S. Nakagawa, The utility of poly(gamma-glutamic acid) nanoparticles as antigen delivery carriers in dendritic cell-based cancer immunotherapy. Biol. Pharm. Bull. 33, 2003 (2010).
32. V. Raffa, O. Vittorio, C. Riggio, and A. Cuschieri, Progress in nanotechnology for healthcare. Minim. Invasive. Ther. Allied. Technol. 19, 127 (2010).
33. C. Longo, G. Gambara, V. Espina, A. Luchini, B. Bishop, A. S. Patanarut, E. F. Petricoin Iii, F. Beretti, B. Ferrari, E. Garaci, A. De Pol, G. Pellacani, and L. A. Liotta, A novel biomarker harvesting nanotechnology identifies Bak as a candidate melanoma biomarker in serum. Exp. Dermatol. 20, 29 (2011).
34. K. Ulbrich, M. Michaelis, F. Rothweiler, T. Knobloch, P. Sithisarn, J. Cinatl, and J. Kreuter, Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells. Int. J. Pharm. 406, 128 (2011).
35. S. Sandhiya, S. A. Dkhar, and A. Surendiran, Emerging trends of nanomedicine - An overview. Fundam. Clin. Pharmacol. 23, 263 (2009).
36. H. Chi, B. Liu, G. Guan, Z. Zhang, and M. Y. Han, A simple, reliable and sensitive colorimetric visualization of melamine in milk by unmodified gold nanoparticles. Analyst. 135, 1070 (2010).
37. Z. Wu, H. Zhao, Y. Xue, Q. Cao, J. Yang, Y. He, X. Li, and Z. Yuan, Colorimetric detection of melamine during the formation of gold nanoparticles. Biosens Bioelectron 26, 2574 (2011).
38. 2 nanoparticles for the sonophotocatalytic degradation of organic pollutants in aqueous environment. Ultrason Sonochem 16, 316 (2009).
39. S. Li, H. Liu, and N. He, Covalent binding of streptavidin on gold magnetic nanoparticles for bead array fabrication. J. Nanosci. Nanotechnol. 10, 4875 (2010).
40. Z. J. Deng, M. Liang, M. Monteiro, I. Toth, and R. F. Minchin, Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nat. Nanotechnol. 6, 39 (2011).
41. K. Chan and T. B. Ng, Isolation and Detection of Protein with Nanoparticles and Microchips for Analyzing Proteomes on a Large Scale Basis. Protein. Pept. Lett. 18, 423 (2011).
42. S. Zhao, X. Ji, P. Lin, and Y. M. Liu, A gold nanoparticle-mediated enzyme bioreactor for inhibitor screening by capillary electrophoresis. Anal. Biochem. 411, 88 (2011).
43. W. J. Trickler, S. M. Lantz, R. C. Murdock, A. M. Schrand, B. L. Robinson, G. D. Newport, J. J. Schlager, S. J. Oldenburg, M. G. Paule, W. Slikker, Jr, S. M. Hussain, and S. F. Ali, Brain microvessel endothelial cells responses to gold nanoparticles: In vitro proinflammatory mediators and permeability. Nanotoxicology December 22 (2010).
44. J. W. Perez, E. A. Vargis, P. K. Russ, F. R. Haselton, and D. W. Wright, Detection of respiratory syncytial virus using nanoparticle amplified immuno-polymerase chain reaction. Anal. Biochem. 410, 141 (2011).
45. H. Zhang, M. H. Harpster, H. J. Park, P. A. Johnson, and W. C. Wilson, Surface-Enhanced Raman Scattering Detection of DNA Derived from the West Nile Virus Genome Using Magnetic Capture of Raman-Active Gold Nanoparticles. Anal. Chem. 83, 254 (2011).
46. A. I. Frenkel, S. Nemzer, I. Pister, L. Soussan, T. Harris, Y. Sun, and M. H. Rafailovich, Size-controlled synthesis and characterization of thiol-stabilized gold nanoparticles. J. Chem. Phys. 123, 184701 (2005).
47. V. Wiwanitkit, A. Seereemaspun, and R. Rojanathanes, Increasing the agglutination reaction in slide test for weak B blood group by gold nanoparticle solution: The first world report. J. Immunol Methods 328, 201 (2007).
48. S. H. Kang, Y. Fukumori, S. Ohnoki, H. Shibata, K. S. Han, H. Nishimukai, and Y. Okubo, Distribution of ABO genotypes and allele frequencies in a Korean population. Jpn. J. Hum. Genet. 42, 331 (1997).
49. D. Cho, M. G. Shin, M. H. Yazer, S. J. Kee, J. H. Shin, S. P. Suh, M. J. Jeon, J. W. Song, C. S. Ki, and D. W. Ryang, The genetic and phenotypic basis of blood group A subtypes in Koreans. Transfus. Med. 15, 329 (2005).
50. J. Chiaroni, D. Legrand, I. Dettori, and V. Ferrera, Analysis of ABO discrepancies occurring in 35 French hospitals. Transfusion. 44, 860 (2004).
51. T. Bianco-Miotto, D. J. Hussey, T. K. Day, D. S. O'Keefe, and A. Dobrovic, DNA methylation of the ABO promoter underlies loss of ABO allelic expression in a significant proportion of leukemic patients. PLoS. One. 4, e4788 (2009).
52. J. Goldstein, L. Lenny, D. Davies, and D. Voak, Further evidence for the presence of A antigen on group B erythrocytes through the use of specific exoglycosidases. Vox. Sang. 57, 142 (1989).
53. A. K. Hult and M. L. Olsson, Many genetically defined ABO subgroups exhibit characteristic flow cytometric patterns. Transfusion. 50, 308 (2010).
54. M. A. Chester and M. L. Olsson, The ABO blood group gene: A locus of considerable genetic diversity. Transfus. Med. Rev. 15, 177 (2001).
55. S. P. Yip, Sequence variation at the human ABO locus. Ann. Hum. Genet. 66, 1 (2002).
56. F. Yamamoto, Review: ABO blood group system-ABH oligosaccharide antigens, anti-A and anti-B, A and B glycosyltransferases, and ABO genes. Immunohematology 20, 3 (2004).
57. F. Yamamoto, H. Clausen, T. White, J. Marken, and S. Hakomori, Molecular genetic basis of the histo-blood group ABO system. Nature 345, 229 (1990).
58. M. H. Yazer, G. A. Denomme, N. L. Rose, and M. M. Palcic, Amino-acid substitution in the disordered loop of blood group B-glycosyltransferase enzyme causes weak B phenotype. Transfusion. 45, 1178 (2005).
59. J. M. Liu, Y. Li, Y. Jiang, and X. P. Yan, Gold nanoparticles amplified ultrasensitive quantification of human urinary protein by capillary electrophoresis with on-line inductively coupled plasma mass spectroscopic detection. J. Proteome. Res. 9, 3545 (2010).
60. S. Tang and I. Hewlett, Nanoparticle-based immunoassays for sensitive and early detection of HIV-1 capsid (p24) antigen. J. Infect. Dis. 201, S59 (2010).
61. Y. Huang, F. Yu, Y. S. Park, J. Wang, M. C. Shin, H. S. Chung, and V. C. Yang, Co-administration of protein drugs with gold nanoparticles to enable percutaneous delivery. Biomaterials 31, 9086 (2010).